Literature DB >> 11164991

Gell and Coombs's classification: is it still valid?

J Descotes1, G Choquet-Kastylevsky.   

Abstract

The Gell and Coombs's classification divides drug allergies into four pathophysiological types, namely anaphylaxis (type I), antibody-mediated cytotoxic reactions (type II), immune complex-mediated reactions (type III), and delayed type hypersensitivity (type IV). Although this classification was proposed more than 30 years ago, it is still widely used. As only a limited number of drug allergies fit into this classification which does not include our current understanding of the immune response, its use is not recommended, particularly in the context of the preclinical safety evaluation of new therapeutic agents. In fact, three different situations can be identified, namely pseudo-allergic reactions, primarily antibody-mediated reactions and cell-mediated reactions, which could serve as a basis for modern and more adequate classifications

Entities:  

Mesh:

Year:  2001        PMID: 11164991     DOI: 10.1016/s0300-483x(00)00400-5

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  12 in total

Review 1.  Immunotoxicology: role in the safety assessment of drugs.

Authors:  Jacques Descotes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Topical Application of the Quaternary Ammonium Compound Didecyldimethylammonium Chloride Activates Type 2 Innate Lymphoid Cells and Initiates a Mixed-Type Allergic Response.

Authors:  Hillary L Shane; Ewa Lukomska; Michael L Kashon; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 3.  How reliable is online diffusion of medical information targeting patients and families?

Authors:  Pedro Xavier-Elsas; Sandra Epifânio Bastos; Maria Ignez C Gaspar-Elsas
Journal:  World J Exp Med       Date:  2015-11-20

Review 4.  Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.

Authors:  J Szebeni; S Fishbane; M Hedenus; S Howaldt; F Locatelli; S Patni; D Rampton; G Weiss; J Folkersen
Journal:  Br J Pharmacol       Date:  2015-10-25       Impact factor: 8.739

Review 5.  Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.

Authors:  Abdelbaset A Elzagallaai; Sandra R Knowles; Michael J Rieder; John R Bend; Neil H Shear; Gideon Koren
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Management of cutaneous drug reactions.

Authors:  K S Babu; Geeta Belgi
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

Review 7.  Allergic adverse reactions to sulfonamides.

Authors:  Geneviève Choquet-Kastylevsky; Thierry Vial; Jacques Descotes
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

Review 8.  Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Authors:  Kalliopi Gerogianni; Aspasia Tsezou; Konstantinos Dimas
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.476

9.  Evaluation of serum immunoglobulins among individuals living near six Superfund sites.

Authors:  Dhelia M Williamson; Mary C White; Charles Poole; David Kleinbaum; Robert Vogt; Kari North
Journal:  Environ Health Perspect       Date:  2006-07       Impact factor: 9.031

Review 10.  IgE-based immunotherapy of cancer: challenges and chances.

Authors:  J Singer; E Jensen-Jarolim
Journal:  Allergy       Date:  2013-10-14       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.